Goldman Sachs Group Inc. Reduces Stock Holdings in iShares Biotechnology ETF $IBB

Goldman Sachs Group Inc. reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 52.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,204,046 shares of the financial services provider’s stock after selling 1,343,824 shares during the quarter. Goldman Sachs Group Inc.’s holdings in iShares Biotechnology ETF were worth $203,207,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of IBB. Darwin Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the 2nd quarter valued at about $25,000. Basepoint Wealth LLC purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $26,000. Cary Street Partners Financial LLC purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $29,000. Copia Wealth Management purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $34,000. Finally, Cornerstone Planning Group LLC purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $35,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Down 1.7%

Shares of NASDAQ:IBB opened at $168.44 on Friday. iShares Biotechnology ETF has a one year low of $123.61 and a one year high of $179.64. The business’s 50-day simple moving average is $169.95 and its 200 day simple moving average is $170.55.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were issued a dividend of $0.1218 per share. This represents a $0.49 annualized dividend and a dividend yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.